Mitchell P. Kopin 13D and 13G filings for MYMD PHARMACEUTICALS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 07:17 am Sale | 2021-12-31 | 13G | MYMD PHARMACEUTICALS INC QCLS | Mitchell P. Kopin | 122 1.000% | -364 (-74.90%) | Filing |